Figure 5
![Figure 5. CsA increases the concentrations of INNO-406 in the CNS. Radioactivity (A) and concentration (B) of INNO-406 in the brains of mice that had been orally administered 30 mg [14C]INNO-406/kg with (○) or without (•) prior administration of 50 mg CsA/kg. Radioactivity (C) and concentration (D) of INNO-406 in the plasma of mice that had been orally administered 30 mg [14C]INNO-406/kg with (○) or without (•) 50 mg CsA/kg. Error bars indicate standard deviation.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/109/1/10.1182_blood-2006-03-013250/4/zh80010706040005.jpeg?Expires=1735518322&Signature=dJJMHNui39cMzDKa~JjW1VlkH5misRrTJH9FA4BhkBEw0632xU4s6Y~-OT-FEt7fzpMUF4NR3qqMx4FIw1CCLlwUCFxEMRa67l7kjfuxEw2Fg0TXSh~982a8uiXSaSUk6P1MrBFcvI9LUEiyTNWNKYqCJWUXqT9PMbOfAkWF92cy0zLSZ4rWvXwtcesZlxROq0PRHocD1MZcM-eLsckfkmA92amo0XoaVTONFmVXO-zj~WlwA~D2KjfkHg4la4d6BIczhWUXQT0OVADe1p3c7NELcNl1kOX6PvB~1H7nRK~yhD9roj52KCj76pgOaeHBxoeUv6ftJrAp~u1K0MxHcQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
CsA increases the concentrations of INNO-406 in the CNS. Radioactivity (A) and concentration (B) of INNO-406 in the brains of mice that had been orally administered 30 mg [14C]INNO-406/kg with (○) or without (•) prior administration of 50 mg CsA/kg. Radioactivity (C) and concentration (D) of INNO-406 in the plasma of mice that had been orally administered 30 mg [14C]INNO-406/kg with (○) or without (•) 50 mg CsA/kg. Error bars indicate standard deviation.
